Considering the protective effects of CRP seen in animal models of lupus, it is tempting to speculate that CRP acts as a modulator of IFN-α production by altering the immune complex handling by plasma-cytoid dendritic cells. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.